Lack of association between four SNPs in the SLC22A3-LPAL2-LPA gene cluster and coronary artery disease in a Chinese Han population: A case control study

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Lv, Xiaofei ^a   Zhang, Yuan ^b   Rao, Shaoqi ^c   Liu, Fengqiong ^a   Zuo, Xiaoyu ^a   Su, Dongfang ^a   Wang, Min ^a   Xia, Min ^a   Guo, Honghui ^d   Feng, Dan ^a   Hong, Changjiang ^b   Li, Dan ^a   Ma, Wenjun ^e   Ouyang, Ping ^c   Li, Xinrui ^a   Feng, Xiang ^a   Yang, Yan ^a   Ling, Wenhua ^a   Qiu, Jian ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b Department of Cardiology   (China)

^c GUANGDONG MEDICAL UNIVERSITY   (China)

^d SHAOGUAN UNIVERSITY   (China)

^e GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Association study; CAD; Lp(a); SLC22A3 LPAL2 LPA; SNP

Indexed keywords

LIPOPROTEIN A; LIPOPROTEIN(A) LIKE 2; ORGANIC CATION TRANSPORTER 3; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; GENE CLUSTER; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; APOLIPOPROTEIN A-II; CASE-CONTROL STUDIES; CHINA; CORONARY ARTERY DISEASE; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MULTIGENE FAMILY; ORGANIC CATION TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84866912278     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-128     Document Type: Article

References (22)

1. Genome-wide haplotype association study identifies the SLC223A-LPL2-LPA gene cluster as a risk locus for coronary artery disease. Trégout DA, König IR, Erdmann J, Munteanu A, Braund PS, Hall AS, Grosshennig A, Linsel-Nitschke P, Perret C, DeSuremain M, Meitinger T, Wright BJ, Preuss M, Balmforth AJ, Ball SG, Meisinger C, Germain C, Evans A, Arveiler D, Luc G, Ruidavets JB, Morrison C, van der Harst P, Schreiber S, Neureuther K, Schäfer A, Bugert P, El Mokhtari NE, Schrezenmeir J, Stark K, et al. Nature Genet 2009 41 283 285 10.1038/ng.314 19198611
2. Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. Kraft HG, Menzel HJ, Hoppichler F, Vogel W, Utermann G, J Clin Invest 1989 83 137 142 10.1172/JCI113849 2521341 (Pubitemid 19048415)
3. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, Marcovina SM, Collins R, Thompson SG, Danesh J, Emerging Risk Factors Collaboration, JAMA 2009 302 412 423 19622820
4. Lipoprotein(a) as a cardiovascular risk factor: Current status. Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A, Eur Heart J 2010 31 2844 2853 10.1093/eurheartj/ehq386 20965889
5. Genetic variants associated with lp(a) lipoprotein level and coronary disease. Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, Heath SC, Parish S, Barlera S, Franzosi MG, Rust S, Bennett D, Silveira A, Malarstig A, Green FR, Lathrop M, Gigante B, Leander K, de Faire U, Seedorf U, Hamsten A, Collins R, Watkins H, Farrall M, N Engl J Med 2009 361 2518 2528 10.1056/NEJMoa0902604 20032323
6. Lp(a) lipoprotein is a major risk factor for cardiovascular disease: Pathogenic mechanisms and clinical significance. Dahlen GH, Stenlund H, Clin Genet 1997 52 272 280 9520117 (Pubitemid 28068615)
7. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH, J Clin Invest 1992 90 52 60 10.1172/JCI115855 1386087
8. Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q. Ober C, Nord AS, Thompson EE, Pan L, Tan Z, Cusanovich D, Sun Y, Nicolae R, Edelstein C, Schneider DH, Billstrand C, Pfaffinger D, Phillips N, Anderson RL, Philips B, Rajagopalan R, Hatsukami TS, Rieder MJ, Heagerty PJ, Nickerson DA, Abney M, Marcovina S, Jarvik GP, Scanu AM, Nicolae DL, J Lipid Res 2009 50 798 806 19124843
9. Comprehensive analysis of genomic variation in the lpa locus and its relationship to plasma lipoprotein(a) in south asians, chinese, and european caucasians. Lanktree MB, Anand SS, Yusuf S, Hegele RA, Circ Cardiovasc Genet 2010 3 39 46 10.1161/CIRCGENETICS.109.907642 20160194
10. Risk polymorphisms and haplotypes identified in genome-wide association studies and their relation with myocardial infarction. Koch W, Hoppmann P, Erl A, Schrempf M, Schatke A, Tuerk S, Mueller JC, Schoemig A, Kastrati A, Eur Heart J 2010 31 801
11. Genetic risk score and risk of myocardial infarction in hispanics. Qi L, Ma J, Qi Q, Hartiala J, Allayee H, Campos H, Circulation 2011 123 374 380 10.1161/CIRCULATIONAHA.110.976613 21242481
12. Genetic polymorphisms of SLC22A3-LPL2-LPA gene cluster has direct and indirect effects on coronary atherosclerosis and coronary heart disease. Sawabe M, Tanaka N, Arai T, Mieno MN, Ikeda S, Muramatsu M, HUGO J 2009 4 107
13. Genetic and clinical correlates of early-outgrowth colony-forming units. Shaw SY, Cheng S, Cupples LA, Larson MG, McCabe EL, Ngwa JS, Wang YA, Martin RP, Klein RJ, Hashmi B, Ajijola OA, Lau E, ODonnell CJ, Vasan RS, Cohen KS, Wang TJ, Circ Cardiovasc Genet 2011 4 296 304 10.1161/CIRCGENETICS.110.958470 21493818
14. Replication of genetic associations withplasma lipoprotein traits in a multiethnic sample. Lanktree MB, Anand SS, Yusuf S, Hegele RA, J Lipid Res 2009 50 1487 1496 10.1194/jlr.P900008-JLR200 19299407
15. Genes, environment, and interactions in prevention of type 2 diabetes: A focus on physical activity and lifestyle changes. Qi L, Hu FB, Hu G, Curr Mol Med 2008 8 519 532 10.2174/156652408785747915 18781959
16. Gene-environment interaction and obesity. Qi L, Cho YA, Nutr Rev 2008 66 684 694 10.1111/j.1753-4887.2008.00128.x 19019037
17. Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes. Qi Q, Workalemahu T, Zhang C, Hu FB, Qi L, Eur Heart J 2011 Epub ahead of print.
18. Joint effects of genetic variants in multiple Loci on the risk of coronary artery disease in chinese han subjects. Lv X, Zhang Y, Rao S, Qiu J, Wang M, Luo X, Zuo X, Su D, Feng X, Yang Y, Ouyang P, Chen Y, Li X, Xiao Y, Ling W, Circ J 2012 76 8 1987 1992 10.1253/circj.CJ-12-0156 22664640
19. Large scale association analysis of novel genetic loci for coronary artery disease. Samani NJ, Deloukas P, Erdmann J, Hengstenberg C, Kuulasmaa K, McGinnis R, Schunkert H, Soranzo N, Thompson J, Tiret L, Ziegler A, Arterioscler Thromb Vasc Biol 2009 29 774 780 19164808
20. Investigating the utility of combining phi29 whole genome amplification and highly multiplexed single nucleotide polymorphism beadarray genotyping. Pask R, Rance HE, Barratt BJ, Nutland S, Smyth DJ, Sebastian M, Twells RC, Smith A, Lam AC, Smink LJ, Walker NM, Todd JA, BMC Biotechnol 2004 4 15 10.1186/1472-6750-4-15 15279678 (Pubitemid 40195472)
21. Genetic association studies: Design, analysis and interpretation. Lewis CM, Brief Bioinform 2002 3 146 153 10.1093/bib/3.2.146 12139434
22. Power and sample size calculations for studies involving linear regression. Dupont WD, Plummer WD Jr, Control Clinical Trials 1998 19 589 601 10.1016/S0197-2456(98)00037-3 (Pubitemid 29057724)